Leaderboards/Hepatitis Viruses Studies and Epidemiology

Hepatitis Viruses Studies and Epidemiology

Last updated July 15, 2026

Rising Stars

Fresh ink, massive impact

Researchers

1
Marı́a Casares-Jiménez
Instituto de Salud Carlos III
2
Sérgio Santos‐Silva
Universidade do Porto
3
Élise Vuille‐Lessard
University of Bern
4
Putu Prathiwi Primadharsini
Jichi Medical University
5
George Ssebyatika
University of Lübeck
6
Lorenz Balcar
Medical University of Vienna
7
Rebecca Fu
Heidelberg University
8
Serena Omo‐Lamai
University of Pennsylvania
9
Zoya Shafat
Jamia Millia Islamia
10
Yinxing Zhu
Washington University in St. Louis

Papers

1
Physicochemical Targeting of Lipid Nanoparticles to the Lungs Induces Clotting: Mechanisms and Solutions
Advanced Materials|2024
101 cit.
2
Limiting endosomal damage sensing reduces inflammation triggered by lipid nanoparticle endosomal escape
Nature Nanotechnology|2025
55 cit.
3
Publication in Viruses (2024) [15 citations, W4398781767]
Viruses|2024
15 cit.
4
Targeting of nanoparticles to the cerebral vasculature after traumatic brain injury
PLoS ONE|2024
12 cit.
5
Serological and molecular survey of rat hepatitis E virus ( <i>Rocahepevirus ratti</i> ) in drug users
Emerging Microbes & Infections|2024
11 cit.
6
Management of varices but not anticoagulation is associated with improved outcome in patients with HCC and macrovascular tumour invasion
Cancer Imaging|2024
8 cit.
7
Publication in Nature Reviews Bioengineering (2025) [8 citations, W4410302308]
Nature Reviews Bioengineering|2025
8 cit.
8
Publication in Veterinary Research Communications (2024) [6 citations, W4400091758]
Veterinary Research Communications|2024
6 cit.
9
A systematic <scp>PCR</scp> record‐based re‐call of <scp>HCV</scp>‐<scp>RNA</scp>‐positive people enables re‐linkage to care and <scp>HCV</scp> elimination in Austria — The <scp>ELIMINATE</scp> project
Liver International|2024
6 cit.
10
Risk of portal hypertensive complications preventable by TIPS in patients with ascites
JHEP Reports|2025
4 cit.

Emerging Leaders

Drafting the new consensus

Researchers

1
Kathleen Dooling
Pfizer (United States)
2
Milan Surjit
International Centre for Genetic Engineering and Biotechnology
3
Zongdi Feng
Nationwide Children's Hospital
4
Ilaria Di Bartolo
Istituto Superiore di Sanità
5
Aaron S. Wallace
Centers for Disease Control and Prevention
6
Su‐Hyung Park
Korea Advanced Institute of Science and Technology
7
Wenhai Yu
Chinese Academy of Medical Sciences & Peking Union Medical College
8
Yogesh A. Karpe
Agharkar Research Institute
9
Siddharth Sridhar
Chinese University of Hong Kong
10
Mohamed A. El‐Mokhtar
Assiut University

Papers

1
Use of Recombinant Zoster Vaccine in Immunocompromised Adults Aged ≥19 Years: Recommendations of the Advisory Committee on Immunization Practices — United States, 2022
MMWR Morbidity and Mortality Weekly Report|2022
236 cit.
2
Routine Vaccination Coverage — Worldwide, 2021
MMWR Morbidity and Mortality Weekly Report|2022
135 cit.
3
Routine Vaccination Coverage — Worldwide, 2022
MMWR Morbidity and Mortality Weekly Report|2023
119 cit.
4
Antiviral Activity of Zinc Oxide Nanoparticles and Tetrapods Against the Hepatitis E and Hepatitis C Viruses
Frontiers in Microbiology|2022
59 cit.
5
Emerging Infections Due to Shewanella spp.: A Case Series of 128 Cases Over 10 Years
Frontiers in Medicine|2022
40 cit.
6
A virtual memory CD8+ T cell-originated subset causes alopecia areata through innate-like cytotoxicity
Nature Immunology|2023
39 cit.
7
Clinical Manifestations of Varicella: Disease Is Largely Forgotten, but It's Not Gone
The Journal of Infectious Diseases|2022
37 cit.
8
Clinical and Bacteriological Analyses of Biofilm-Forming Staphylococci Isolated from Diabetic Foot Ulcers
Infection and Drug Resistance|2023
23 cit.
9
Independent Evaluation of Cell Culture Systems for Hepatitis E Virus
Viruses|2022
22 cit.
10
A small animal model of chronic hepatitis E infection using immunocompromised rats
JHEP Reports|2022
22 cit.

Current Senior Leaders

Wrote the book, still writing it

Researchers

1
Robert H. Purcell
National Institutes of Health
2
Hiroaki Okamoto
Jichi Medical University
3
Xiang‐Jin Meng
Virginia–Maryland College of Veterinary Medicine
4
Jacques Izopet
Hôpital Purpan
5
Stanley M. Lemon
Bipar
6
Ningshao Xia
Xiamen University
7
Lionel Rostaing
Centre Hospitalier Universitaire de Grenoble
8
Marion Koopmans
Erasmus MC
9
Jaime Bosch
University Hospital of Bern
10
Robert M. Hoekstra
Centers for Disease Control and Prevention

Papers

1
The Global Burden of Nontyphoidal<i>Salmonella</i>Gastroenteritis
Clinical Infectious Diseases|2010
2.5k cit.
2
Portal hypertensive bleeding in cirrhosis
Hepatology|2016
2.1k cit.
3
Hepatitis E Virus and Chronic Hepatitis in Organ-Transplant Recipients
New England Journal of Medicine|2008
1.3k cit.
4
Typing hepatitis C virus by polymerase chain reaction with type-specific primers: application to clinical surveys and tracing infectious sources
Journal of General Virology|1992
1.3k cit.
5
Early Use of TIPS in Patients with Cirrhosis and Variceal Bleeding
New England Journal of Medicine|2010
1.2k cit.
6
Transmission of SARS-CoV-2 on mink farms between humans and mink and back to humans
Science|2020
1.2k cit.
7
Hepatic Venous Pressure Gradient Predicts Clinical Decompensation in Patients With Compensated Cirrhosis
Gastroenterology|2007
1.2k cit.
8
A novel virus in swine is closely related to the human hepatitis E virus
Proceedings of the National Academy of Sciences|1997
1.1k cit.
9
Immune evasion by hepatitis C virus NS3/4A protease-mediated cleavage of the Toll-like receptor 3 adaptor protein TRIF
Proceedings of the National Academy of Sciences|2005
1.1k cit.
10
Typing Hepatitis B Virus by Homology in Nucleotide Sequence: Comparison of Surface Antigen Subtypes
Journal of General Virology|1988
1.1k cit.

Reagents for Hepatitis Viruses Studies and Epidemiology

Citation-validated products used in this field

🔥 Trending

Gaining adoption fast

Thermo Fisher Scientific

Mouse IgG Fc Isotype Control

#31205
View Evidence →

⭐ Top Rated

Best all-around

Cell Signaling TechnologyEvidence 60

Image-iT® FX Signal Enhancer

#11932$165
View Evidence →
Cell Signaling Technology

ELL (D7N6U) Rabbit Monoclonal Antibody

#14468$161,351
View Evidence →
Cell Signaling TechnologyEvidence 66

SH3BP4 (D3D9I) Rabbit Monoclonal Antibody

#55935$161,351
View Evidence →

🌟 All-Time

Most validated

Cell Signaling TechnologyEvidence 65

alpha-Synuclein (E4U2F) Feline Chimeric Monoclonal Antibody

Cited in 14 papers
#79642$161,384
View Evidence →
Agilent/Dako

Hepatitis B Virus Core Antigen

Cited in 10 papers
#B0586
View Evidence →
Cell Signaling TechnologyEvidence 65

Phospho-c-Jun (Ser73) (D47G9) Rabbit Monoclonal Antibody (Alexa Fluor® 488 Conjugate)

#12714$493
View Evidence →